Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugs

References

• Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376(9738), 367–387. https://doi.org/10.1016/s0140-6736(10)60829-x
   PubMed Web of Science ®Google Scholar
• Altice, F. L., Mostashari, F., & Friedland, G. H. (2001). Trust and the acceptance of and adherence to antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 28(1), 47–58. https://doi.org/10.1097/00042560-200109010-00008
   PubMed Web of Science ®Google Scholar
• Antinori, A., Coenen, T., Costagiola, D., Dedes, N., Ellefson, M., Gatell, J., Girardi, E., Johnson, M., Kirk, O., Lundgren, J., Mocroft, A., D'Arminio Monforte, A., Phillips, A., Raben, D., Rockstroh, J. K., Sabin, C., Sönnerborg, A., & De Wolf, F. (2011). Late presentation of HIV infection: A consensus definition. HIV Medicine, 12(1), 61–64. https://doi.org/10.1111/j.1468-1293.2010.00857.x
   PubMed Web of Science ®Google Scholar
• Bach, P., Wood, E., Dong, H., Guillemi, S., Kerr, T., Montaner, J., & Milloy, M. J. (2015). Association of patterns of methadone use with antiretroviral therapy discontinuation: A prospective cohort study. BMC Infectious Diseases, 15(1), 537. https://doi.org/10.1186/s12879-015-1255-7
   PubMedGoogle Scholar
• Berg, K. M., Litwin, A., Li, X., Heo, M., & Arnsten, J. H. (2011). Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial. Drug and Alcohol Dependence, 113(2–3), 192–199. https://doi.org/10.1016/j.drugalcdep.2010.07.025
   PubMed Web of Science ®Google Scholar
• Brown, A. E., Hayes, R., Noori, T., Azad, Y., Amato-Gauci, A. J., Pharris, A., & Delpech, V. C. (2018). HIV in Europe and Central Asia: Progress in 2018 towards meeting the UNAIDS 90-90-90 targets. Eurosurveillance, 23(48), 48. https://doi.org/10.2807/1560-7917.Es.2018.23.48.1800622
   Web of Science ®Google Scholar
• Cohen, S. M., Hu, X., Sweeney, P., Johnson, A. S., & Hall, H. I. (2014). HIV viral suppression among persons with varying levels of engagement in HIV medical care, 19 US jurisdictions. JAIDS Journal of Acquired Immune Deficiency Syndromes, 67(5), 519–527. https://doi.org/10.1097/qai.0000000000000349
   PubMed Web of Science ®Google Scholar
• Crawford, T. N., & Thornton, A. (2017). Retention in continuous care and sustained viral suppression. Journal of the International Association of Providers of AIDS Care (JIAPAC), 16(1), 42–47. https://doi.org/10.1177/2325957416678929
   PubMedGoogle Scholar
• Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., Lynskey, M., Griffiths, P., Mattick, R. P., Hickman, M., & Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet Global Health, 5(12), e1192–e1207. https://doi.org/10.1016/s2214-109x(17)30375-3
   PubMed Web of Science ®Google Scholar
• DiMatteo, M. R. (2004). Social support and patient adherence to medical treatment: A meta-analysis. Health Psychology, 23(2), 207–218. https://doi.org/10.1037/0278-6133.23.2.207
   PubMed Web of Science ®Google Scholar
• Eisinger, R. W., & Fauci, A. S. (2018). Ending the HIV/AIDS pandemic (1). Emerging Infectious Diseases, 24(3), 413–416. https://doi.org/10.3201/eid2403.171797
   PubMed Web of Science ®Google Scholar
• Hart, J. E., Jeon, C. Y., Ivers, L. C., Behforouz, H. L., Caldas, A., Drobac, P. C., & Shin, S. S. (2010). Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: A meta-analysis and systematic review. JAIDS Journal of Acquired Immune Deficiency Syndromes, 54(2), 167–179. https://doi.org/10.1097/QAI.0b013e3181d9a330
   PubMed Web of Science ®Google Scholar
• Lin, D., Zhang, C. Y., He, Z. K., & Zhao, X. D. (2019). How does hard-to-reach status affect antiretroviral therapy adherence in the HIV-infected population? Results from a meta-analysis of observational studies. BMC Public Health, 19(1), 789. https://doi.org/10.1186/s12889-019-7135-0
   PubMedGoogle Scholar
• Low, A. J., Mburu, G., Welton, N. J., May, M. T., Davies, C. F., French, C., Turner, K. M., Looker, K. J., Christensen, H., McLean, S., Rhodes, T., Platt, L., Hickman, M., Guise, A., & Vickerman, P. (2016). Impact of opioid substitution therapy on antiretroviral therapy outcomes: A systematic review and meta-analysis. Clinical Infectious Diseases, 63(8), 1094–1104. https://doi.org/10.1093/cid/ciw416
   PubMed Web of Science ®Google Scholar
• Meade, C. S., Conn, N. A., Skalski, L. M., & Safren, S. A. (2011). Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. Journal of Behavioral Medicine, 34(2), 128–138. https://doi.org/10.1007/s10865-010-9293-5
   PubMed Web of Science ®Google Scholar
• Montaner, J. S., Wood, E., Kerr, T., Lima, V., Barrios, R., Shannon, K., Harrigan, R., & Hogg, R. (2010). Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes. JAIDS Journal of Acquired Immune Deficiency Syndromes, 55(Suppl 1), S5–S9. https://doi.org/10.1097/QAI.0b013e3181f9c1f0
   PubMed Web of Science ®Google Scholar
• Mugavero, M. J., Amico, K. R., Westfall, A. O., Crane, H. M., Zinski, A., Willig, J. H., Dombrowski, J. C., Norton, W. E., Raper, J. L., Kitahata, M. M., & Saag, M. S. (2012). Early retention in HIV care and viral load suppression: Implications for a test and treat approach to HIV prevention. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59(1), 86–93. https://doi.org/10.1097/QAI.0b013e318236f7d2
   PubMed Web of Science ®Google Scholar
• Roux, P., Carrieri, M. P., Villes, V., Dellamonica, P., Poizot-Martin, I., Ravaux, I., & Spire, B. (2008). The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: Evidence from the MANIF2000 cohort study. Addiction, 103(11), 1828–1836. https://doi.org/10.1111/j.1360-0443.2008.02323.x
   PubMed Web of Science ®Google Scholar
• Stein, R., Xu, S., Marano, M., Williams, W., Cheng, Q., Eke, A., Moore, A., & Wang, G. (2017). HIV testing, linkage to HIV medical care, and interviews for partner services among women – 61 Health Department jurisdictions, United States, Puerto Rico, and the U.S. Virgin Islands, 2015. MMWR. Morbidity and Mortality Weekly Report, 66(41), 1100–1104. https://doi.org/10.15585/mmwr.mm6641a2
   PubMed Web of Science ®Google Scholar
• Teasdale, C. A., Wang, C., Francois, U., Ndahimana, J., Vincent, M., Sahabo, R., El-Sadr, W. M., & Abrams, E. J. (2015). Time to initiation of antiretroviral therapy among patients who are ART eligible in Rwanda: Improvement over time. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68(3), 314–321. https://doi.org/10.1097/qai.0000000000000432
   PubMed Web of Science ®Google Scholar
• Teira, R., Espinosa, N., Gutiérrez, M. M., Montero, M., Martínez, E., González, F., Lozano de León, F., Téllez, F., Galindo, M. J., Peraire, J., Deig, E., & Muñoz-Sánchez, P. (2019). Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors. Enfermedades Infecciosas y Microbiología Clínica, 37(6), 361–366. https://doi.org/10.1016/j.eimc.2018.09.008
   Web of Science ®Google Scholar
• Uhlmann, S., Milloy, M. J., Kerr, T., Zhang, R., Guillemi, S., Marsh, D., Hogg, R. S., Montaner, J. S. G., & Wood, E. (2010). Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction, 105(5), 907–913. https://doi.org/10.1111/j.1360-0443.2010.02905.x
   PubMed Web of Science ®Google Scholar
• Yehia, B. R., Fleishman, J. A., Metlay, J. P., Moore, R. D., & Gebo, K. A. (2012). Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA, 308(4), 339–342. https://doi.org/10.1001/jama.2012.5927
   PubMed Web of Science ®Google Scholar